Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01372891
What this trial is testing

Urine Adiponectin Concentration in Prediction of Contrast Induced Nephropathy

Who this might be right for
Myocardial Ischemia
Xijing Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT05931276
What this trial is testing

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Who this might be right for
End-Stage Kidney DiseaseEnd-Stage Renal Disease
VA Office of Research and Development 2,540
Post-approval studies (Phase 4)Study completedNCT00725517
What this trial is testing

Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange

Who this might be right for
Chronic Kidney DiseasePeritoneal Dialysis
Shanghai Jiao Tong University School of Medicine 2
Large-scale testing (Phase 3)Study completedNCT03357874
What this trial is testing

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.

Who this might be right for
Acute Coronary Syndrome
Assistance Publique Hopitaux De Marseille 259
Not applicableUnknownNCT02450474
What this trial is testing

Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis

Who this might be right for
Kidney Failure
The Leeds Teaching Hospitals NHS Trust 12
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Not applicableStudy completedNCT00005417
What this trial is testing

Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives

Who this might be right for
Cardiovascular DiseasesHeart DiseasesHypertension+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT06369597
What this trial is testing

Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery

Who this might be right for
Liver CancerRenal CancerRectal Cancer
Sun Yat-sen University 177
Not applicableStudy completedNCT02194790
What this trial is testing

Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
Bhumirajanagarindra Kidney Institute, Thailand 238
Post-approval studies (Phase 4)UnknownNCT05824390
What this trial is testing

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
XIEJINGYUAN 116
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Large-scale testing (Phase 3)Study completedNCT01847313
What this trial is testing

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Karl Neff 20
Not applicableUnknownNCT05193474
What this trial is testing

Evaluate Serious Illness Treatment Preferences and Outcomes in the Patients Receiving Peritoneal Dialysis

Who this might be right for
ESRDPeritoneal Dialysis
National Taiwan University Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00237718
What this trial is testing

Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

Who this might be right for
End-stage Renal Disease
Vanderbilt University 385
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT00517413
What this trial is testing

LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 163
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Not applicableUnknownNCT00592618
What this trial is testing

Effect of NAC on Sleep Apnea

Who this might be right for
ESRDSleep Apnea
Assaf-Harofeh Medical Center
Not applicableStudy completedNCT02233010
What this trial is testing

Usefulness of Neutrophil Gelatinase-associated Lipocalin(NGAL) to Confirm Acute Kidney Function Decrease of the Patients Who Had Non-cardiac Surgery

Who this might be right for
Chronic Kidney Disease
Inje University 43
Testing effectiveness (Phase 2)Looking for participantsNCT04438213
What this trial is testing

Ertugliflozin in Chronic Heart Failure

Who this might be right for
Heart Failure
Yale University 60
Next Page